|
⚲
|
| Keyboard |
| Eagan Patrick
✚
|
|
|---|---|
| CIK # | 0001550371 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001550371] | |
| 4 | [0001550371] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Eagan Patrick | |
| Allergan PLC | |
| Watson Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Allergan PLC ACT
Ordinary Shares
|
2013-11-04 | Sell | 7,200 | $156.71 | 1,128,312 |
|
Allergan PLC ACT
Ordinary Shares
|
2013-10-01 | Grant | 14,209 | ||
|
Watson Pharmaceuticals Inc ACT
Common Stock, par value $0.0033
|
2013-10-01 | Disposed to issuer | 14,209 | ||
|
Watson Pharmaceuticals Inc ACT
Common Stock, par value $0.0033
|
2013-09-30 | Tax withheld | 15,291 | $144.00 | 2,201,904 |
|
Watson Pharmaceuticals Inc ACT
Common Stock, par value $0.0033
|
2013-09-30 | Option exercise | 2,851 | ||
|
Watson Pharmaceuticals Inc ACT
Common Stock, par value $0.0033
|
2013-09-30 | Grant | 11,952 | ||
|
Watson Pharmaceuticals Inc ACT
Restricted Stock Units · derivative
|
2013-09-30 | Option exercise | 2,851 | $0.00 | |
|
Watson Pharmaceuticals Inc ACT
Common Stock, par value $0.0033
|
2013-03-06 | Grant | 2,948 | $0.00 | |
|
Watson Pharmaceuticals Inc ACT
Common Stock, par value $0.0033
|
2013-03-06 | Grant | 3,070 | $0.00 | |
|
Watson Pharmaceuticals Inc WPI
Common Stock, par value $0.0033
|
2012-10-31 | Grant | 2,909 | $0.00 |